Skip to main content
. 2021 Aug 12;10(8):968. doi: 10.3390/antibiotics10080968

Figure 9.

Figure 9

Docking poses of quercetin, kaempferol, and chrysin inside the active site of E. coli’s Gyr-B (AC, respectively) alongside the binding pose of the co-crystalized inhibitor (D). RMSDs of quercetin, kaempferol, and chrysin inside the active site of E. coli’s Gyr-B during 50 ns of MDS (E).